Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dirofilaria immitis, commonly known as heartworm, is a parasitic nematode that resides in the pulmonary arteries and right ventricle of infected hosts, primarily dogs. The adult worms cause vascular damage, leading to pulmonary hypertension and congestive heart failure. Therapeutic strategies target different stages of the heartworm life cycle, focusing on preventing infection and eliminating adult worms. The ecdysone receptor pathway, dependent on Wolbachia symbiosis, represents a potential drug target. Understanding the molecular and cellular features of D. immitis is crucial for developing effective and safe treatments.
Heartworm preventatives: Interfere with nerve and muscle function of microfilariae and larvae. Adulticides: Arsenical compound that kills adult heartworms.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dirofilaria immitis (Adult Heartworms).